ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Gylden Pharma Limited

Gylden Pharma Limited is an active company incorporated on 18 January 2016 with the registered office located in Abingdon, Oxfordshire. Gylden Pharma Limited was registered 9 years ago.
Status
Active
Active since incorporation
Company No
09955881
Private limited company
Age
9 years
Incorporated 18 January 2016
Size
Small
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Overdue
Confirmation statement overdue by 79 days
Dated 7 August 2024 (1 year 3 months ago)
Next confirmation dated 7 August 2025
Was due on 21 August 2025 (2 months ago)
Last change occurred 1 year 3 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Unaudited Abridged
Next accounts for period 31 March 2025
Due by 31 December 2025 (1 month remaining)
Address
4 & 5 Dunmore Court Wootton Road
Abingdon
Oxfordshire
OX13 6BH
England
Same address for the past 9 years
Telephone
01235 527589
Email
Unreported
People
Officers
9
Shareholders
90
Controllers (PSC)
1
Director • Luxembourger • Lives in UK • Born in May 1971
Director • American • Lives in United States • Born in Sep 1954
Director • Singaporean • Lives in Singapore • Born in Mar 1983
Director • American • Lives in England • Born in May 1950
Director • British • Lives in England • Born in Dec 1948
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Lascaux Pharmaceuticals Limited
Professor Thomas William Rademacher is a mutual person.
Active
Burges Grove Management Company Limited
David Clifford Jackson is a mutual person.
Active
Sylus Pharmaceuticals Ltd
Professor Thomas William Rademacher is a mutual person.
Active
Gylden Limited
Storme Jo-Anne Moore-Thornicroft is a mutual person.
Active
Barsoom Limited
Storme Jo-Anne Moore-Thornicroft is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
£517K
Decreased by £1.92M (-79%)
Turnover
Unreported
Same as previous period
Employees
39
Increased by 10 (+34%)
Total Assets
£7.26M
Decreased by £3.66M (-33%)
Total Liabilities
-£5.46M
Increased by £1.4M (+35%)
Net Assets
£1.8M
Decreased by £5.06M (-74%)
Debt Ratio (%)
75%
Increased by 38.03% (+102%)
Latest Activity
New Charge Registered
1 Month Ago on 10 Sep 2025
Abridged Accounts Submitted
3 Months Ago on 23 Jul 2025
Michael Derek Vaughn Rake Resigned
1 Year 2 Months Ago on 3 Sep 2024
Confirmation Submitted
1 Year 3 Months Ago on 9 Aug 2024
Mr Sergio Pagani Details Changed
1 Year 3 Months Ago on 12 Jul 2024
Xinhong Lim Resigned
1 Year 10 Months Ago on 5 Jan 2024
Dr Poh Hui Chia Appointed
1 Year 10 Months Ago on 5 Jan 2024
Group Accounts Submitted
2 Years Ago on 16 Oct 2023
Dr Ricardo De Godoi Mattos Ferreira Appointed
2 Years 1 Month Ago on 27 Sep 2023
Confirmation Submitted
2 Years 2 Months Ago on 16 Aug 2023
Get Credit Report
Discover Gylden Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 9 October 2025
Submitted on 22 Oct 2025
Registration of charge 099558810002, created on 10 September 2025
Submitted on 30 Sep 2025
Unaudited abridged accounts made up to 31 March 2024
Submitted on 23 Jul 2025
Resolutions
Submitted on 19 May 2025
Memorandum and Articles of Association
Submitted on 13 May 2025
Memorandum and Articles of Association
Submitted on 13 May 2025
Memorandum and Articles of Association
Submitted on 13 May 2025
Statement of capital following an allotment of shares on 18 December 2024
Submitted on 20 Jan 2025
Resolutions
Submitted on 28 Dec 2024
Statement of capital following an allotment of shares on 12 December 2024
Submitted on 12 Dec 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year